When Will Tumor Mutational Burden be a Standard Trials analyzing responses, not FDA-approved yet - 100459

Spotlight
Video

When Will Tumor Mutational Burden be a Standard Trials analyzing responses, not FDA-approved yet

moasc has 333 videos Subscribe Here

Loading........
Description: Karen Reckamp, MD, MS Medical Director, Clinical Research Operations
shares When Will Tumor Mutational Burden be a Standard Trials analyzing responses, not FDA-approved yet at the 2018 Oncology Summit in Huntington Beach, CA

Go to: http://www.moasc.org... for more information
Shared By : moasc
Posted on : 03/06/18
Added : 10 months ago



Recommended

Nothing found.